Domoprednate
| Code | Size | Price |
|---|
| TAR-T31563-5mg | 5mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Domoprednate is a synthetic glucocorticoid corticosteroid. The brand name is Stermonid.
CAS:
66877-67-6
Formula:
C26H36O5
Molecular Weight:
428.569
Purity:
0.98
SMILES:
CCCC(=O)O[C@@]1(CCC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C)C(C)=O
References
1. Schmidt H, Hjorth N, Holm P. Domoprednate, a new nonhalogenated topical steroid: comparison to hydrocortisone butyrate. Dermatologica. 1987;175(3):145-7. PubMed PMID: 3653463.
2. Christiansen JV, Foged E, Holm P, J?rgensen AS, Reymann F. The treatment of psoriasis with 0.1% domoprednate (a D-homocorticosteroid) and 0.1% betamethasone valerate ointment. A double-blind, randomized trial. Dermatologica. 1985;170(4):195-8. PubMed PMID: 3888709.
3. Serup J, Holm P. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo. Dermatologica. 1985;170(4):189-94. PubMed PMID: 3888708.
4. Schmidt H, Hjorth N, Holm P. A randomized trial on the D-homosteroid domoprednate (Ro 12-7024) in the treatment of dermatoses. Dermatologica. 1984;168(3):127-30. PubMed PMID: 6370748.